Generex gets another Canadian patent for aerosol formulations

Generex has received a patent from the Canadian Intellectual Property Office for its aerosol drug delivery platform, its 162nd patent for the technology. Although the company announcement emphasizes its buccal delivery platform, the patent is titled Aerosol Formulations for Buccal and Pulmonary Application. Generex’s Oral-lyn buccal insulin spray is delivered via pMDI. Read the company’s press release.